This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.63% per year. These returns cover a period from January 1, 1988 through December 2, 2019. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Horace Mann Educators Corporation (HMN) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Horace Mann (HMN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Should Value Investors Buy Horace Mann Educators (HMN) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Horace Mann (HMN) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Horace Mann (HMN) delivered earnings and revenue surprises of +29.52% and +1.78%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Why Horace Mann (HMN) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Horace Mann (HMN) have what it takes? Let's find out.
Horace Mann (HMN) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Horace Mann (HMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Assurant Boosts Automation Prospects With OptoFidelity Technology (Revised)
by Zacks Equity Research
AIZ acquires OptoFidelity's technology to benefit the Connected Living business of its Global Lifestyle segment.
Horace Mann (HMN) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Horace Mann (HMN) have what it takes? Let's find out.
Assurant Acquires OptoFidelity & Boosts Automation Prospects
by Zacks Equity Research
AIZ acquires OptoFidelity to benefit the Connected Living business of its Global Lifestyle segment.
MMC Sub-Unit Mercer Launches AI Platforms to Aid HR Teams
by Zacks Equity Research
Marsh & McLennan sub-unit Mercer launches AI-driven Workforce Insights and Aida to empower HR teams with data-backed decisions and global workforce intelligence.
MTG Stock Near 52-Week High: A Signal for Investors to Hold Tight?
by Zacks Equity Research
MGIC Investment gains from new business, solid annual persistency, higher levels of home sales, effective capital deployment, and sufficient liquidity.
Are You Looking for a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Horace Mann (HMN) have what it takes? Let's find out.
Prudential Financial Trades at a Discount: Time to Load Up or Hold Off?
by Zacks Equity Research
PRU relies on global growth, strong insurance sales and PGIM integration to offset margin pressures from debt and low rates.
Are Investors Undervaluing Horace Mann Educators (HMN) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Radian Group Trades Above 50-Day SMA: How to Play the Stock?
by Zacks Equity Research
RDN strengthens its mortgage insurance base with steady loan quality, rising renewals and disciplined capital deployment.
Why Horace Mann (HMN) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Horace Mann (HMN) have what it takes? Let's find out.
Will WTW's Radar Deal With Sompo Transform Insurance Pricing?
by Zacks Equity Research
Willis Towers Watson partners with Sompo to deploy Radar, driving smarter pricing, client stickiness, and recurring revenues.
MET Adds Cancer Support Benefit to Upgrade Critical Illness Plan
by Zacks Equity Research
MetLife enhances its Critical Illness Insurance with a new Cancer Support benefit, offering enhanced care and guidance from Private Health Management experts for patients starting in 2026.
MTG Outperforms Industry, Hits 52-Week High: How to Play the Stock
by Zacks Equity Research
MGIC Investment gains from new business, solid annual persistency, higher levels of home sales, effective capital deployment, and sufficient liquidity.
ORI Hits 52-Week High, Trades at a Discount: How to Play the Stock
by Zacks Equity Research
Old Republic International gains from solid market presence, low property catastrophe exposure in its General Insurance segment and strong capital position.
MFC Rolls Out Travel Agent Platform With Enhanced Digital Tools
by Zacks Equity Research
Manulife Canada launches a digital platform for travel agents, adding products and tools to boost insurance sales and client engagement.
Prudential Expands EssentialTerm Suite With Added Coverage Flexibility
by Zacks Equity Research
PRU expands its EssentialTerm Suite, adding higher coverage options and flexible features to meet evolving financial needs.
Why Horace Mann (HMN) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Horace Mann (HMN) have what it takes? Let's find out.
Prudential Financial Trades Above 50-Day SMA: How to Play the Stock?
by Zacks Equity Research
PRU's gains on the back of global expansion, pension risk transfers and strategic moves, while debt and low rates challenge margins.
Assurant Teams Up With Holman to Boost Global Automotive Division
by Zacks Equity Research
AIZ expands partnership with Holman, strengthening its Global Automotive division and boosting customer experience.
Horace Mann (HMN) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Horace Mann (HMN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).